A detailed history of Kathmere Capital Management, LLC transactions in Viatris Inc stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 11,441 shares of VTRS stock, worth $143,241. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,441
Previous 12,598 9.18%
Holding current value
$143,241
Previous $133,000 0.75%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$10.32 - $12.13 $11,940 - $14,034
-1,157 Reduced 9.18%
11,441 $132,000
Q2 2024

Jul 17, 2024

SELL
$10.05 - $12.02 $165,543 - $197,993
-16,472 Reduced 56.66%
12,598 $133,000
Q2 2024

Jul 01, 2024

BUY
$10.05 - $12.02 $1,999 - $2,391
199 Added 0.69%
29,070 $309,000
Q1 2024

Apr 16, 2024

SELL
$11.27 - $13.53 $2,242 - $2,692
-199 Reduced 0.68%
28,871 $344,000
Q4 2023

Apr 16, 2024

SELL
$8.77 - $10.85 $122,253 - $151,249
-13,940 Reduced 32.41%
29,070 $314,000
Q3 2023

Oct 11, 2023

SELL
$9.59 - $11.35 $13,387 - $15,844
-1,396 Reduced 3.14%
43,010 $424,000
Q2 2023

Jul 11, 2023

BUY
$9.02 - $10.29 $154,079 - $175,773
17,082 Added 62.52%
44,406 $443,000
Q1 2023

Apr 20, 2023

BUY
$9.2 - $12.26 $136,362 - $181,717
14,822 Added 118.56%
27,324 $262,000
Q4 2022

Jan 24, 2023

SELL
$8.72 - $11.56 $14,004 - $18,565
-1,606 Reduced 11.38%
12,502 $0
Q4 2022

Jan 24, 2023

BUY
$8.72 - $11.56 $123,021 - $163,088
14,108 New
14,108 $0
Q1 2021

May 07, 2021

SELL
$13.59 - $18.54 $1,100 - $1,501
-81 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $1,158 - $1,517
81 New
81 $2,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Kathmere Capital Management, LLC Portfolio

Follow Kathmere Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.